The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 2, Pages 400
Publisher
MDPI AG
Online
2021-02-16
DOI
10.3390/cells10020400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
- (2020) John Y. L. Chiang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation
- (2020) Sidhartha R. Sinha et al. Cell Host & Microbe
- Obeticholic acid for the treatment of NASH
- (2020) Jordan Hindson Nature Reviews Gastroenterology & Hepatology
- Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
- (2020) Aonghus Lavelle et al. Nature Reviews Gastroenterology & Hepatology
- Symmetrically substituted dichlorophenes inhibit N-acyl-phosphatidylethanolamine phospholipase D
- (2020) Geetika Aggarwal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vitamin D receptor promotes healthy microbial metabolites and microbiome
- (2020) Ishita Chatterjee et al. Scientific Reports
- A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
- (2020) Meilin Wei et al. EBioMedicine
- Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism
- (2020) Charlotte Lefort et al. Cells
- Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level
- (2020) Douglas J. Kenny et al. Cell Host & Microbe
- Bile acids drive the newborn’s gut microbiota maturation
- (2020) N. van Best et al. Nature Communications
- Mucus barrier, mucins and gut microbiota: the expected slimy partners?
- (2020) Paola Paone et al. GUT
- Targeting the alternative bile acid synthetic pathway for metabolic diseases
- (2020) Wei Jia et al. Protein & Cell
- Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis
- (2019) Amandine Everard et al. Nature Communications
- Hepatic MyD88 regulates liver Inflammation by altering the synthesis of oxysterols
- (2019) Charlotte Lefort et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Oxysterol research: a brief review
- (2019) William J. Griffiths et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Ursodeoxycholic Acid Accelerates Bile Acid Enterohepatic Circulation
- (2019) Yunjing Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Elevated oxysterol levels in human and mouse livers reflect non-alcoholic steatohepatitis
- (2019) Tina Raselli et al. JOURNAL OF LIPID RESEARCH
- Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients
- (2019) Jessica R. Allegretti et al. Clinical Gastroenterology and Hepatology
- Regulations of bile acid metabolism in mouse models with hydrophobic bile acid composition
- (2019) Akira Honda et al. JOURNAL OF LIPID RESEARCH
- Bile acid metabolites control TH17 and Treg cell differentiation
- (2019) Saiyu Hang et al. NATURE
- Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease
- (2019) Yingfei Xi et al. BIOMEDICINE & PHARMACOTHERAPY
- Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
- (2019) Xinyang Song et al. NATURE
- Farnesoid X receptor: A “homeostat” for hepatic nutrient metabolism
- (2018) Vittoria Massafra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
- (2018) Preeti Pathak et al. HEPATOLOGY
- Update on FXR Biology: Promising Therapeutic Target?
- (2018) Chang Han INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Vitamin D deficiency and the pathogenesis of Crohn’s disease
- (2018) John H. White JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Liver X receptors in lipid signalling and membrane homeostasis
- (2018) Bo Wang et al. Nature Reviews Endocrinology
- Progress and challenges of selective Farnesoid X Receptor modulation
- (2018) Vittoria Massafra et al. PHARMACOLOGY & THERAPEUTICS
- Role of Bile Acids in Metabolic Control
- (2018) Antonio Molinaro et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- New approaches and challenges to targeting the endocannabinoid system
- (2018) Vincenzo Di Marzo NATURE REVIEWS DRUG DISCOVERY
- Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
- (2018) Samer Al-Dury et al. Frontiers in Pharmacology
- A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters
- (2018) Mao-xu Ge et al. ACTA PHARMACOLOGICA SINICA
- Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD
- (2018) Cyrielle Caussy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Colitis alters oxysterol metabolism and is affected by 4β-hydroxycholesterol administration
- (2018) Owein Guillemot-Legris et al. Journal of Crohns & Colitis
- Oxysterols in intestinal immunity and inflammation
- (2018) T. Willinger JOURNAL OF INTERNAL MEDICINE
- LXR Suppresses Inflammatory Gene Expression and Neutrophil Migration through cis-Repression and Cholesterol Efflux
- (2018) David G. Thomas et al. Cell Reports
- Gut microbiome structure and metabolic activity in inflammatory bowel disease
- (2018) Eric A. Franzosa et al. Nature Microbiology
- Liver X receptors link lipid metabolism and inflammation
- (2017) Ira G. Schulman FEBS LETTERS
- Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
- (2017) Gilaad G. Kaplan et al. GASTROENTEROLOGY
- Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
- (2017) Oscar Chávez-Talavera et al. GASTROENTEROLOGY
- Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration
- (2017) Gloria Alvarez-Sola et al. GUT
- Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
- (2017) Na Jiao et al. GUT
- The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
- (2017) Puneet Puri et al. HEPATOLOGY
- Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials
- (2017) Morten Hansen et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance
- (2017) Manuel Lasalle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice
- (2017) Bérengère Benoit et al. NATURE MEDICINE
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Clinical relevance of the bile acid receptor TGR5 in metabolism
- (2017) F Samuel van Nierop et al. Lancet Diabetes & Endocrinology
- Obesity
- (2017) Pedro González-Muniesa et al. Nature Reviews Disease Primers
- BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
- (2017) Adriana Carino et al. Scientific Reports
- Bile Acid Recognition by NAPE-PLD
- (2016) Eleonora Margheritis et al. ACS Chemical Biology
- Oxysterols: Old Tale, New Twists
- (2016) Winnie Luu et al. Annual Review of Pharmacology and Toxicology
- Current trends in oxysterol research
- (2016) William J. Griffiths et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells
- (2016) Andrea Kristina Horst et al. Cellular & Molecular Immunology
- 27-Hydroxycholesterol suppresses lipid accumulation by down-regulating lipogenic and adipogenic gene expression in 3T3-L1 cells
- (2016) Bungo Shirouchi et al. CYTOTECHNOLOGY
- Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers
- (2016) R. Pencek et al. DIABETES OBESITY & METABOLISM
- Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
- (2016) Thibaut Duparc et al. GUT
- Microbiota-induced obesity requires farnesoid X receptor
- (2016) Ava Parséus et al. GUT
- Recent Progress on Bile Acid Receptor Modulators for Treatment of Metabolic Diseases
- (2016) Yanping Xu JOURNAL OF MEDICINAL CHEMISTRY
- Oxysterols: From cholesterol metabolites to key mediators
- (2016) Valentin Mutemberezi et al. PROGRESS IN LIPID RESEARCH
- Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet–fed mice
- (2016) Anuradha Rao et al. Science Translational Medicine
- Oxysterols in Metabolic Syndrome: From Bystander Molecules to Bioactive Lipids
- (2016) Owein Guillemot-Legris et al. TRENDS IN MOLECULAR MEDICINE
- 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome
- (2016) Jiho Jang et al. Nature Communications
- Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
- (2016) Marialena Mouzaki et al. PLoS One
- Obesity is associated with changes in oxysterol metabolism and levels in mice liver, hypothalamus, adipose tissue and plasma
- (2016) Owein Guillemot-Legris et al. Scientific Reports
- Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect
- (2016) Hua Cao et al. Scientific Reports
- Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial
- (2016) Ronald Biemann et al. Scientific Reports
- Development and validation of an HPLC-MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and ceramides: variations in metabolic syndrome
- (2015) Valentin Mutemberezi et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- De novolipogenesis in the liver in health and disease: more than just a shunting yard for glucose
- (2015) Francis W. B. Sanders et al. BIOLOGICAL REVIEWS
- Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
- (2015) Brian C. Ferslew et al. DIGESTIVE DISEASES AND SCIENCES
- Latest approaches for the treatment of obesity
- (2015) V Margaret Jackson et al. Expert Opinion on Drug Discovery
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
- (2015) Jessica Zucman-Rossi et al. GASTROENTEROLOGY
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
- (2015) Chiara Degirolamo et al. NATURE REVIEWS DRUG DISCOVERY
- Endocannabinoids — at the crossroads between the gut microbiota and host metabolism
- (2015) Patrice D. Cani et al. Nature Reviews Endocrinology
- Effect of obesity and metabolic syndrome on plasma oxysterols and fatty acids in human
- (2015) Marie Tremblay-Franco et al. STEROIDS
- Individual bile acids have differential effects on bile acid signaling in mice
- (2015) Peizhen Song et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota
- (2015) Lucie Geurts et al. Nature Communications
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Structure-based drug design targeting the cell membrane receptor GPBAR1: exploiting the bile acid scaffold towards selective agonism
- (2015) Francesco Saverio Di Leva et al. Scientific Reports
- LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling
- (2015) Ayaka Ito et al. eLife
- Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice
- (2015) Daniel A. Briere et al. PLoS One
- Bile acids and the gut microbiome
- (2014) Jason M. Ridlon et al. CURRENT OPINION IN GASTROENTEROLOGY
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Liver disease in infancy caused by oxysterol 7α-hydroxylase deficiency: successful treatment with chenodeoxycholic acid
- (2014) Dongling Dai et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Relative roles ofABCG5/ABCG8in liver and intestine
- (2014) Jin Wang et al. JOURNAL OF LIPID RESEARCH
- Design, Synthesis, and Biological Evaluation of Potent Dual Agonists of Nuclear and Membrane Bile Acid Receptors
- (2014) Claudio D’Amore et al. JOURNAL OF MEDICINAL CHEMISTRY
- Modification on Ursodeoxycholic Acid (UDCA) Scaffold. Discovery of Bile Acid Derivatives As Selective Agonists of Cell-Surface G-Protein Coupled Bile Acid Receptor 1 (GP-BAR1)
- (2014) Valentina Sepe et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal
- (2014) Johannes Schmitt et al. LIVER INTERNATIONAL
- The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice
- (2014) T Jakobsson et al. Mucosal Immunology
- Liver X receptors in lipid metabolism: opportunities for drug discovery
- (2014) Cynthia Hong et al. NATURE REVIEWS DRUG DISCOVERY
- Oxysterols are agonist ligands of ROR t and drive Th17 cell differentiation
- (2014) P. Soroosh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status
- (2014) Amandine Everard et al. Nature Communications
- Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition
- (2013) Javier Vaquero et al. BIOCHEMICAL PHARMACOLOGY
- Pleiotropic Roles of Bile Acids in Metabolism
- (2013) Thomas Q. de Aguiar Vallim et al. Cell Metabolism
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Human Insulin Resistance Is Associated With Increased Plasma Levels of 12 -Hydroxylated Bile Acids
- (2013) R. A. Haeusler et al. DIABETES
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- The TGR5 receptor mediates bile acid–induced itch and analgesia
- (2013) Farzad Alemi et al. JOURNAL OF CLINICAL INVESTIGATION
- Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes
- (2013) S. Caron et al. MOLECULAR AND CELLULAR BIOLOGY
- Sterols and oxysterols in immune cell function
- (2013) Nathanael J Spann et al. NATURE IMMUNOLOGY
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
- (2012) Seiki Miura et al. BMC CANCER
- Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
- (2012) Luciano Adorini et al. DRUG DISCOVERY TODAY
- Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
- (2012) Henri Duboc et al. GUT
- Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice
- (2012) Bo Kong et al. HEPATOLOGY
- Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease
- (2012) Tadashi Ikegami et al. JOURNAL OF GASTROENTEROLOGY
- Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein–1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease
- (2012) Qianming Bai et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Liver X receptor biology and pharmacology: new pathways, challenges and opportunities
- (2012) Tomas Jakobsson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
- (2011) Thijs W.H. Pols et al. Cell Metabolism
- Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
- (2011) J. Prawitt et al. DIABETES
- The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice
- (2011) Yan-Dong Wang et al. HEPATOLOGY
- Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
- (2011) Mitsuhiro Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
- (2011) Tingting Li et al. MOLECULAR ENDOCRINOLOGY
- Oxysterols direct immune cell migration via EBI2
- (2011) Sébastien Hannedouche et al. NATURE
- Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism
- (2011) M. Bertolotti et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
- (2011) Sabrina Cipriani et al. PLoS One
- Vitamin D metabolism and signaling in the immune system
- (2011) John H. White REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease
- (2010) Zhao-Xia Yang et al. Hepatology International
- LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice
- (2010) Rucha Patel et al. JOURNAL OF CLINICAL INVESTIGATION
- Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
- (2010) G. Rizzo et al. MOLECULAR PHARMACOLOGY
- The LDL Receptor
- (2009) Joseph L. Goldstein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
- (2009) Vivian A. Fonseca et al. DIABETES OBESITY & METABOLISM
- Bile acid levels are increased in the liver of patients with steatohepatitis
- (2009) Márcia M. Aranha et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Modulation of Retinoic Acid Receptor-related Orphan Receptor α and γ Activity by 7-Oxygenated Sterol Ligands
- (2009) Yongjun Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Bile acids: regulation of synthesis
- (2009) John Y. L. Chiang JOURNAL OF LIPID RESEARCH
- Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity
- (2009) Roberto Pellicciari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Neonatal Cholestatic Liver Disease in an Asian Patient With a Homozygous Mutation in the Oxysterol 7α-hydroxylase Gene
- (2009) Isao Ueki et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Bile acids: Chemistry, physiology, and pathophysiology
- (2009) Maria J Monte et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Antiatherosclerotic effect of farnesoid X receptor
- (2008) Andrea Mencarelli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure−Activity Relationships, and Molecular Modeling Studies
- (2008) Hiroyuki Sato et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lithocholic acid down-regulation of NF-κB activity through vitamin D receptor in colonic cancer cells
- (2008) Jun Sun et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started